Cefuroxime-MIP-1500mg-EE-I - UnicomIG v0.1.0

UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions

Example Ingredient: Cefuroxime-MIP-1500mg-EE-I

Generated Narrative: Ingredient Cefuroxime-MIP-1500mg-EE-I

status: Active

for:

MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#EE-100009199-27834,http://ema.europa.eu/fhir/pmsId#EE0000002; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder for solution for injection/infusion; legalStatusOfSupply = Medicinal Product subject to medical prescription; classification = Cefuroxime,cefuroxime
ManufacturedItemDefinition: status = active; manufacturedDoseForm = Powder for solution for injection/infusion; unitOfPresentation = Vial
AdministrableProductDefinition: status = active; administrableDoseForm = Solution for injection/infusion; unitOfPresentation = Vial

role: Active

substance
Codes
- Concept
* CEFUROXIME SODIUM
strength
presentation: 1578 milligram(s) (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')/1 Vial (Details: Unit of Presentation EMA code200000002158 = 'Vial')
referenceStrength
Substances
- Concept
* CEFUROXIME
strength: 1500 milligram(s) (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')/1 Vial (Details: Unit of Presentation EMA code200000002158 = 'Vial')

Links: Table of Contents | QA Report

The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.